Germany's Merck Raises Guidance Again on Growth Across Units
By Adria Calatayud
Germany's Merck KGaA raised its annual guidance for the third time this year, citing top-line growth across its businesses and favorable currency movements.
The Darmstadt, Germany-based conglomerate said Thursday that it expects full-year net sales to range between 21.5 billion and 21.9 billion euros ($23.84 billion-$24.29 billion), against its prior forecast of between 21 billion and 21.8 billion euros.
Earnings before interest, taxes, depreciation and amortization excluding one-time items for the year are forecast at between 6.2 billion and 6.4 billion euros, which compares with previous guidance of 5.9 billion to 6.3 billion euros.
"Our upgraded full-year guidance reflects our confidence that Merck will continue to deliver solid performance in 2026," Chief Executive Kai Beckmann said.
For the third quarter, Merck reported an after-tax profit of 450 million euros, down 50% compared with the year-earlier period, when its results benefited from one-off gains.
Excluding one-time items, Ebitda was up 0.8% at 1.68 billion euros, the company said. Analysts polled by Vara Research had forecast the metric at 1.61 billion euros.
Net sales grew 5.8% to 5.63 billion euros, beating consensus estimates of 5.46 billion euros. Quarterly sales grew 5.1% organically, Merck said.
Write to Adria Calatayud at adria.calatayud@wsj.com
(END) Dow Jones Newswires
November 12, 2026 01:23 ET (06:23 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular

4 Growth Stocks to Buy While They’re Still Undervalued

3 of the Best Core Stocks to Own

3 Great New ETFs From 2026

Retirees: 5 Reasons to Consider Index Funds and ETFs

